Petr Svoboda

Effect of intravenous corticosteroids on death within 14 days in 10 008 adults with clinically significant head injury (MRC CRASH trial): randomised placebo-controlled trial

Ian Roberts, David Yates, Peter Sandercock et al. · The Lancet · 2004 · 1.1K citations

Traumatic Brain Injury, Significant Head Injury, Clinical Injury +11

Efficacy and Safety of Tifacogin (Recombinant Tissue Factor Pathway Inhibitor) in Severe Sepsis

Edward Abraham, Konrad Reinhart, Steven M. Opal et al. · JAMA · 2003 · 951 citations

Final results of MRC CRASH, a randomised placebo-controlled trial of intravenous corticosteroid in adults with head injury—outcomes at 6 months

Phil Edwards, Miguel Arango, Laura Balica et al. · The Lancet · 2005 · 840 citations

Traumatic Brain Injury, Medicine, Head Injury—outcomes +6

Assessment of the safety of recombinant tissue factor pathway inhibitor in patients with severe sepsis: A multicenter, randomized, placebo-controlled, single-blind, dose escalation study

Edward Abraham, Konrad Reinhart, Petr Svoboda et al. · Critical Care Medicine · 2001 · 252 citations

Stress ulcer prophylaxis in critically ill patients: a randomized controlled trial.

Ilona Kantorová, Petr Svoboda, Peter Scheer et al. · PubMed · 2004 · 184 citations